Works matching DE "RAF genes"


Results: 88
    1
    2
    3
    4
    5
    6
    7
    8

    Active surrender.

    Published in:
    Pigment Cell & Melanoma Research, 2012, v. 25, n. 3, p. 292, doi. 10.1111/j.1755-148X.2012.00991.x
    By:
    • Collisson, Eric A.
    Publication type:
    Article
    9

    Senescence-escape in melanoma.

    Published in:
    Pigment Cell & Melanoma Research, 2012, v. 25, n. 4, p. 408, doi. 10.1111/j.1755-148X.2012.01021.x
    By:
    • Liu, Wenjin;
    • Sharpless, Norman E.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    BRAF V600E-Negative Hairy Cell Leukaemia.

    Published in:
    Case Reports in Hematology, 2013, p. 1, doi. 10.1155/2013/513049
    By:
    • Langabeer, Stephen E.;
    • O'Brien, David;
    • McElligott, Anthony M.;
    • Lavin, Michelle;
    • Browne, Paul V.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.

    Published in:
    PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0185862
    By:
    • Merchant, Mark;
    • Moffat, John;
    • Schaefer, Gabriele;
    • Chan, Jocelyn;
    • Wang, Xi;
    • Orr, Christine;
    • Cheng, Jason;
    • Hunsaker, Thomas;
    • Shao, Lily;
    • Wang, Stephanie J.;
    • Wagle, Marie-Claire;
    • Lin, Eva;
    • Haverty, Peter M.;
    • Shahidi-Latham, Sheerin;
    • Ngu, Hai;
    • Solon, Margaret;
    • Eastham-Anderson, Jeffrey;
    • Koeppen, Hartmut;
    • Huang, Shih-Min A.;
    • Schwarz, Jacob
    Publication type:
    Article
    35
    36
    37

    The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.

    Published in:
    Nature Genetics, 2015, v. 47, n. 3, p. 250, doi. 10.1038/ng.3218
    By:
    • Lin, Luping;
    • Chan, Elton;
    • Olivas, Victor;
    • Cade, Lindsay;
    • Pazarentzos, Evangelos;
    • Asthana, Saurabh;
    • Neel, Dana;
    • Yan, Jenny Jiacheng;
    • Lu, Xinyuan;
    • Pham, Luu;
    • Wang, Mingxue M;
    • Collisson, Eric A;
    • Algazi, Alain;
    • Bivona, Trever G;
    • Muñoz-Couselo, Eva;
    • Cortes, Javier;
    • Frederick, Dennie T;
    • Flaherty, Keith T;
    • Cooper, Zachary A;
    • Wargo, Jennifer A
    Publication type:
    Article
    38

    Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3.

    Published in:
    Journal of Clinical Investigation, 2013, v. 123, n. 5, p. 2155, doi. 10.1172/JCI65780
    By:
    • Abel, Ethan V.;
    • Basile, Kevin J.;
    • Kugel III, Curtis H.;
    • Witkiewicz, Agnieszka K.;
    • Le, Kaitlyn;
    • Amaravadi, Ravi K.;
    • Karakousis, Giorgos C.;
    • Xiaowei Xu;
    • Wei Xu;
    • Schuchter, Lynn M.;
    • Lee, Jason B.;
    • Ertel, Adam;
    • Fortina, Paolo;
    • Aplin, Andrew E.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Correction.

    Published in:
    2012
    Publication type:
    Correction Notice
    49

    A-Raf: A new star of the family of raf kinases.

    Published in:
    Critical Reviews in Biochemistry & Molecular Biology, 2015, v. 50, n. 6, p. 520, doi. 10.3109/10409238.2015.1102858
    By:
    • An, Su;
    • Yang, Yang;
    • Ward, Richard;
    • Liu, Ying;
    • Guo, Xiao-Xi;
    • Xu, Tian-Rui
    Publication type:
    Article
    50